Preferences of inflammatory arthritis patients for biological disease-modifying antirheumatic drugs in the first 100 days of the COVID-19 pandemic

BACKGROUND/AIM: To evaluate treatment adherence and predictors of drug discontinuation among patients with inflammatory arthritis receiving bDMARDs within the first 100 days after the announcement of the COVID-19 pandemic. MATERIALS AND METHODS: A total of 1871 patients recorded in TReasure registry...

Descripción completa

Detalles Bibliográficos
Autores principales: KALYONCU, Umut, PEHLİVAN, Yavuz, AKAR, Servet, KAŞİFOĞLU, Timuçin, KİMYON, Gezmiş, KARADAĞ, Ömer, DALKILIÇ, Ediz, ERTENLİ, Ali İhsan, KILIÇ, Levent, ERSÖZLÜ, Duygu, BES, Cemal, EMMUNGİL, Hakan, MERCAN, Rıdvan, EDİBOĞLU, Elif Durak, KANITEZ, Nilüfer, BİLGİN, Emre, ÇOLAK, Seda, KOCA, Süleyman Serdar, GÖNÜLLÜ, Emel, KÜÇÜKŞAHİN, Orhan, COŞKUN, Nihan, YAĞIZ, Burcu, KİRAZ, Sedat
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Scientific and Technological Research Council of Turkey 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8569786/
https://www.ncbi.nlm.nih.gov/pubmed/33611869
http://dx.doi.org/10.3906/sag-2012-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8569786/
https://www.ncbi.nlm.nih.gov/pubmed/33611869
http://dx.doi.org/10.3906/sag-2012-5

Ejemplares similares